AGP Executive Report
Last update: 3 hours agoEbola Response in Congo: A WHO-backed clinical trial has started in eastern Congo to test a monoclonal antibody (MBP134) and an antiviral (remdesivir) against the Bundibugyo Ebola virus, as the outbreak grows to 1,400+ confirmed cases and 438 deaths. Rapid Testing Push: A separate effort is narrowing down five manufacturers for a rapid antigen test that could deliver results in the field within weeks, aiming to speed up isolation and containment. Congo River Science: New research tracks how the Congo River’s massive freshwater flow (about 40,000 cubic metres per second) gets trapped by swirling ocean currents and carried hundreds of kilometres into the Atlantic—affecting circulation, climate, and fisheries. Wildlife Monitoring: African manatees have been confirmed in the Tchimpounga Nature Reserve, with plans for long-term acoustic monitoring to protect their habitat. Fintech Growth in Congo: Optasia reports strong momentum in microfinancing and expects revenue growth of up to 60%, citing expansion that includes the Republic of Congo.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
